Answers are grounded in this paper and cite their sources.
(Nat Cell Biol, doi: 10.1038/s41556-020-0481-4) demonstrate that copper binds with high affinity to a designated interaction site in the pro-autophagic kinases ULK1 and ULK2. Chelation of copper or genetic deletion of this copper-binding site inhibits autophagy and hence reduces the fitness of KRAS-induced cancers. These findings suggest that copper chelation might constitute a novel therapeutic intervention on autophagy-dependent malignancies.
No takes yet. Share an insight, caveat, or question.
Zischka et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: